346 related articles for article (PubMed ID: 34812107)
1. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis.
Zhang Y; Ogbu D; Garrett S; Xia Y; Sun J
Gut Microbes; 2021; 13(1):1996848. PubMed ID: 34812107
[TBL] [Abstract][Full Text] [Related]
2. Probiotics and microbial metabolites maintain barrier and neuromuscular functions and clean protein aggregation to delay disease progression in TDP43 mutation mice.
Zhang Y; Xia Y; Sun J
Gut Microbes; 2024; 16(1):2363880. PubMed ID: 38860943
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of ALCAT1 mitigates amyotrophic lateral sclerosis by attenuating SOD1 protein aggregation.
Liu X; Zhang J; Li J; Song C; Shi Y
Mol Metab; 2022 Sep; 63():101536. PubMed ID: 35772643
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
5. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
[TBL] [Abstract][Full Text] [Related]
6. Target Metabolites to Slow Down Progression of Amyotrophic Lateral Sclerosis in Mice.
Ogbu D; Zhang Y; Claud K; Xia Y; Sun J
Metabolites; 2022 Dec; 12(12):. PubMed ID: 36557291
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
8. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.
Bros-Facer V; Krull D; Taylor A; Dick JR; Bates SA; Cleveland MS; Prinjha RK; Greensmith L
Hum Mol Genet; 2014 Aug; 23(16):4187-200. PubMed ID: 24667415
[TBL] [Abstract][Full Text] [Related]
9. Repurposing carbamazepine for the treatment of amyotrophic lateral sclerosis in SOD1-G93A mouse model.
Zhang JJ; Zhou QM; Chen S; Le WD
CNS Neurosci Ther; 2018 Dec; 24(12):1163-1174. PubMed ID: 29656576
[TBL] [Abstract][Full Text] [Related]
10. Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis.
Zhang YG; Wu S; Yi J; Xia Y; Jin D; Zhou J; Sun J
Clin Ther; 2017 Feb; 39(2):322-336. PubMed ID: 28129947
[TBL] [Abstract][Full Text] [Related]
11. Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset.
Rocha MC; Pousinha PA; Correia AM; Sebastião AM; Ribeiro JA
PLoS One; 2013; 8(9):e73846. PubMed ID: 24040091
[TBL] [Abstract][Full Text] [Related]
12. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
[TBL] [Abstract][Full Text] [Related]
13. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into RAGE signaling pathways during the progression of amyotrophic lateral sclerosis in RAGE-deficient SOD1 G93A mice.
Nowicka N; Zglejc-Waszak K; Juranek J; Korytko A; Wąsowicz K; Chmielewska-Krzesińska M; Wojtkiewicz J
PLoS One; 2024; 19(3):e0299567. PubMed ID: 38457412
[TBL] [Abstract][Full Text] [Related]
15. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
[TBL] [Abstract][Full Text] [Related]
16. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
[TBL] [Abstract][Full Text] [Related]
17. Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models.
Kato S; Kato M; Abe Y; Matsumura T; Nishino T; Aoki M; Itoyama Y; Asayama K; Awaya A; Hirano A; Ohama E
Acta Neuropathol; 2005 Aug; 110(2):101-12. PubMed ID: 15983830
[TBL] [Abstract][Full Text] [Related]
18. Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice.
Figueroa-Romero C; Guo K; Murdock BJ; Paez-Colasante X; Bassis CM; Mikhail KA; Pawlowski KD; Evans MC; Taubman GF; McDermott AJ; O'Brien PD; Savelieff MG; Hur J; Feldman EL
Dis Model Mech; 2019 Nov; 13(2):. PubMed ID: 31597644
[TBL] [Abstract][Full Text] [Related]
19. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
20. R13 preserves motor performance in SOD1
Li X; Chen C; Zhan X; Li B; Zhang Z; Li S; Xie Y; Song X; Shen Y; Liu J; Liu P; Liu GP; Yang X
Theranostics; 2021; 11(15):7294-7307. PubMed ID: 34158851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
